Table 2.
Psychotomimetic effects and side‐effect profiles following treatment
| A, 0.5 mg/kg | B, 0.2 kg/kg | C, Placebo | F or χ 2 | P‐value | |
|---|---|---|---|---|---|
| BPRS changes (40 min vs. baseline) | −20.5% (21.0%) | −18.3% (19.1%) | −10.0% (10.4%) | 1.614 | 0.210 |
| BPRS changes (80 min vs. baseline) | −23.9% (24.1%) | −20.0% (18.3%) | −12.5% (20.4%) | 1.578 | 0.218 |
| BPRS changes (120 min vs. baseline) | −22.9% (24.3%) | −22.3% (17.7%) | −14.2% (11.2%) | 1.094 | 0.344 |
| BPRS changes (240 min vs. baseline) | −23.6% (23.1%) | −21.9% (17.4%) | −15.5% (12.2%) | 0.877 | 0.423 |
| Floating Sensations | 8 | 1 | 0 | 15.590 | 0.000** |
| Dissociation | 1 | 0 | 0 | 2.043 | 0.360 |
| Dizziness/Nausea | 2 | 1 | 2 | 0.447 | 0.800 |
| Chest tightness | 2 | 1 | 0 | 2.133 | 0.344 |
| Others (Crying) | 2 | 0 | 1 | 2.133 | 0.344 |
Note. BPRS, Brief psychiatric rating scale positive symptoms subscale.
**P < 0.05.